< back to main site

Publications

Acquisition and management of high content screening, light-sheet microscopy and mass spectrometry imaging data at AstraZeneca, GlaxoSmithKline and NPL: a survey report

Cooke, E; Hayes, M; Romanchikova, M; Dexter, A; Steven, R; Thomas, S; Shaw, M; Pilling, J; Ling, S; Strittmatter, N; Ivanov, D; Wang, Y; Race, A; Fraser, D; Francis, J; Newman, C; West, A; Lavelle, J (2020) Acquisition and management of high content screening, light-sheet microscopy and mass spectrometry imaging data at AstraZeneca, GlaxoSmithKline and NPL: a survey report. NPL Report. MS 25

[img]
Preview
Text (NPL Report MS 25)
MS25.pdf - Published Version

Download (3MB) | Preview

Abstract

This survey has been conducted between October 2018 and April 2019 as a part of a collaborative project "Federation of Imaging Data for Life sciences research" (FIDL). During the survey, National Physical Laboratory (NPL) Data Science team interviewed scientists from AstraZeneca (AZ), GlaxoSmithKline (GSK) and NPL bio-metrology group to depict the landscape of the instruments and data management methods in three imaging domains: high content screening, mass spectrometry imaging and light-sheet microscopy. This report compares the commonly used instruments, data acquisition, data management and data processing strategies used in AZ, GSK and NPL laboratories.

Item Type: Report/Guide (NPL Report)
NPL Report No.: MS 25
Keywords: data management, metadata, mass spectrometry imaging, lightsheet microscopy, fluorescent microscopy, bioimaging
Subjects: Mathematics and Scientific Computing > Software Engineering
Divisions: Data Science
Identification number/DOI: 10.47120/npl.MS25
Last Modified: 15 Jun 2021 08:03
URI: http://eprintspublications.npl.co.uk/id/eprint/8839

Actions (login required)

View Item View Item